we have investigated the therapeutic effects of a combination of cyclophosphamide ( cy , 150 mg/kg , iv ) and human recombinant interleukin 2 ( il-2 , 5 x 10 ( 4 ) ju/day , ip for 5 days ) on autochthonous tumors induced in mice by 3-methylcholanthrene .
C0086418
human
C0021756
il-2